-

DeciBio Spins off Technology Products as a Subsidiary Entity, DeciBio Analytics

LOS ANGELES--(BUSINESS WIRE)--Last year, DeciBio Consulting announced the formation of DeciBio Analytics, a subsidiary entity that develops market intelligence informatics tools and technologies and informatics-oriented consulting work. With the mission to accelerate commercialization of innovation in the precision medicine space by building novel and propriety solutions that empower our clients, DeciBio Analytics will continue to develop both open platforms and proprietary tools that enable clients to better harness and analyze the wealth of information continuously generated about the precision medicine industry.

A wholly-owned subsidiary of DeciBio Consulting, DeciBio Analytics is led by Pranay Madan, who initiated the entity’s original efforts and is responsible for developing and executing DeciBio Analytics’ product strategy. Pranay Madan received a bachelor’s in Bio-technology Engineering from Panjab University and a master’s in Business & Science from Keck Graduate Institute. He joined DeciBio in 2014 and has since deployed multiple advanced analytical platforms across major Life Science and Healthcare clients. More information about DeciBio Analytics can be found at its website: https://www.decibio-analytics.com/

About DeciBio

DeciBio Consulting is a boutique strategy consulting and market research firm focusing on the life science industry. DeciBio's mission is to provide the market intelligence and strategic insights that drive disruption and innovation in precision medicine.

Headquartered in Los Angeles, CA, DeciBio serves clients and customers across the globe, ranging from incubator-stage startups to Fortune 500 healthcare corporations. DeciBio addresses business solutions in the areas of market landscape analysis, product development, voice-of-customer feedback, new product launches, technology assessment, competitive landscape analysis, business case strategy, and commercial due diligence.

Contacts

DeciBio Analytics
Jessica Lee
jessica.lee@decibio.com
310.451.4510

DeciBio Consulting


Release Summary
Precision medicine consulting firm, DeciBio Consulting, spins off its data intelligence and software division as a subsidiary, DeciBio Analytics.
Release Versions

Contacts

DeciBio Analytics
Jessica Lee
jessica.lee@decibio.com
310.451.4510

Social Media Profiles
More News From DeciBio Consulting

Worldwide In Vitro Diagnostics (IVD) Market Forecasted to Grow at 4% p.a., Reaching $109B by 2030 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--According to a comprehensive market report authored by DeciBio Consulting LLC, “In Vitro Diagnostic (IVD) Market Report 2025-2030”, the global in vitro diagnostics market is predicted to reach $109B by 2030. This growth will be driven by increasing access to and adoption of diagnostics, the development of new therapies requiring ongoing testing, and the rise of emerging technologies (e.g., computational pathology, liquid biopsy) poised to gain clinical traction and...

Proteomics Tools Market Forecast to Grow at ~4% p.a., Reaching ~$39B by 2030 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, “Proteomics Tools Report: Research and Clinical markets (2025-2030).” This comprehensive report forecasts the global proteomics tools market to reach approximately $39 billion by 2030, growing at a compound annual growth rate (CAGR) of ~4% from an estimated $32 billion in 2025. DeciBio’s Proteomics Tools Market Report offers an in-dept...

Pharma R&D Services Market Forecast to Grow at 5% p.a., Reaching ~$129B by 2029 – Market Report by DeciBio Consulting LLC

LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, “Pharma R&D Services Market Report (2024-2029).” This comprehensive report forecasts the global pharma R&D services market to reach approximately $129 billion by 2029, growing at a compound annual growth rate (CAGR) of 5% from an estimated $101 billion in 2024. DeciBio’s Pharma R&D Services Market Report offers an in-depth...
Back to Newsroom